Development of an animal model for autoimmune hepatitis

自身免疫性肝炎动物模型的建立

基本信息

  • 批准号:
    7267898
  • 负责人:
  • 金额:
    $ 7.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our goal is to develop a novel animal model for autoimmune hepatitis (AIH). AIM is a severe adverse immune reaction afflicting the liver, resulting in the progressive destruction of the parenchyma. To date no valid animal model is available that reflects the clinical and pathological features of human AIH and allows to study its etiology and immunopathology. A hallmark of AIH is the presence of liver/kidney microsomal antibodies that recognize the cytochrome P450 isoform 2D6 (CYP2D6) as a major target autoantigen. Thus, it is the objective to break tolerance to a transgenically expressed target antigen (human CYP2D6) in the target organ (liver) of CYP2D6-mice by infection of a liver-tropic virus (adenovirus), ensuring local inflammation and delivery of large quantities of the triggering antigen (human CYP2D6). From preliminary experiments we know that this approach results in persistent liver damage in CYP2D6-mice, which is characterized by lymphocyte infiltration, hepatic fibrosis, and high titer anti-CYP2D6 antibodies. In addition to its obvious benefit as a novel model to study AIH, the CYP2D6 mouse may also be used as a proof of principle for studying general mechanisms involved in fibrinogenesis and in drug-induced autoimmune diseases that are mediated by members of the cytochrome P450 family, such as Halothane hepatitis (CYP2E1) or procainamide-induced lupus (CYP2D6). Aim 1: Development and characterization of the CYP2D6-mouse model for autoimmune hepatitis Aim 2: Mechansims of autoimmune liver damage in the CYP2D-mouse model; Aim 3: Evaluation of possible treatments to abrogate autoimmunity in the CYP2D6-mouse model.
描述(申请人提供):我们的目标是发展一种新的自身免疫性肝炎(AIH)动物模型。AIM是一种严重的免疫不良反应,困扰肝脏,导致实质进行性破坏。到目前为止,还没有有效的动物模型可以反映人类AIH的临床和病理特征,并允许研究其病因学和免疫病理学。AIH的一个特征是存在肝/肾微粒体抗体,该抗体将细胞色素P450亚型2D6(CYP2D6)识别为主要的靶标自身抗原。因此,目的是通过感染嗜肝病毒(腺病毒)来打破小鼠对转基因表达的靶抗原(人CYP2D6)的耐受性,确保局部炎症和大量触发抗原(人CYP2D6)的传递。从初步实验中我们知道,这种方法会导致CYP2D6转基因小鼠的持续性肝损伤,其特征是淋巴细胞浸润、肝纤维化和高滴度的抗CYP2D6抗体。除了作为研究AIH的新模型的明显益处外,CYP2D6小鼠还可以被用作研究纤维蛋白形成和由细胞色素P450家族成员介导的药物诱导的自身免疫性疾病的一般机制的原理证明,如氟烷肝炎(CYP2E1)或普鲁卡因胺诱导的狼疮(CYP2D6)。 目的1:自身免疫性肝炎模型的建立及特性研究目的2:自身免疫性肝损伤的机制;目的3:评价消除自身免疫性肝炎的可能治疗方法。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
  • DOI:
    10.1084/jem.20071859
  • 发表时间:
    2008-06-09
  • 期刊:
  • 影响因子:
    15.3
  • 作者:
    Holdener, Martin;Hintermann, Edith;Bayer, Monika;Rhode, Antje;Rodrigo, Evelyn;Hintereder, Gudrun;Johnson, Eric F.;Gonzalez, Frank J.;Pfeilschifter, Josef;Manns, Michael P.;Herrath, Matthias von G.;Christen, Urs
  • 通讯作者:
    Christen, Urs
Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?
  • DOI:
    10.1016/j.jaut.2009.08.001
  • 发表时间:
    2010-02
  • 期刊:
  • 影响因子:
    12.8
  • 作者:
    Christen U;Hintermann E;Holdener M;von Herrath MG
  • 通讯作者:
    von Herrath MG
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

URS CHRISTEN其他文献

URS CHRISTEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('URS CHRISTEN', 18)}}的其他基金

Development of an animal model for autoimmune hepatitis
自身免疫性肝炎动物模型的建立
  • 批准号:
    6952538
  • 财政年份:
    2006
  • 资助金额:
    $ 7.77万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 7.77万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了